USPTO serial 85632415
SILANES
Reviewed by CopyMark Law Group
Reg. 4654888Status 710
- Filing date
- Status date
- Registration date
- Dec 16, 2014
- Examiner
- I, DAVID C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with SILANES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Laboratorios Silanes S.A. DE C.V.
Mexico DF, MX
Laboratorios Silanes S.A. DE C.V.
Mexico DF, MX
Laboratorios Silanes S.A. DE C.V.
Mexico DF, MX
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Henry J. Cittone
HENRY J. CITTONE CITTONE & CHINTA LLP11 Broadway - Suite 615New York, NY 10004UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, namely, injectable solutions, tablets, pills and capsules for adults and children, oral suspensions, medicated syrups and ointments, all for treatment as a cough suppressant, and expectorant, having activity against anaerobic bacteria, trichomona vaginalis, entamoeba histolytica, and giardia lamblia, as an antifungal agent for treatment of oropharyngeal and esophageal candidiasis, candidal urinary tract infections, peritonitis and systemic candidal infections, candidemia, disseminated candidiasis and pneumonia, cryptococcal meningitis, candidal genital tract infections, as an analgesis anti-inflamatory non steroidal inhibitor of prostaglandin synthetase, analgesic and minor tranquilizer, active immunization against tetanus, peripheral neuritis, neuralgias, peripheral neuritis, neuralgias and haematopoietics, antifungal agents for treatment of systemic blastomycosis, histoplasmosis paracoccidloidomycosis, fungal infection of the gastrointestinal tract and tinea infections of the skin and nails, sulphonylurea and biguanide, hipoglycaemic agent, activity against trichomonas vaginalis, entamoeba histolytica and giardia lamblia, anaerobic bacteria, histamine h1-receptor antagonist and prophylactic treatment of asthma, and treatment of allergic conditions such as rhinitis and conjunctivitis, analgesic, anti-inflamatory non steroidal, for inhibiting prostaglandin synthetase, analgesic, anti-inflammatory non steroidal, inhibitor of prostaglandin synthetase and muscle relaxant, analgesic, antipyretic, sulphonylurea hipoglycaemic agent, for inhibiting as an angiotensin-converting enzyme, treatment of congestive heart failure and asymptomatic left ventricular dysfunction, diuretic treatment of congestive heart failure, hypertension, cardiac, renal hepatogenic oedema, peripheral neuritis, neuralgias and analgesic, a broad spectrum antibiotic, effective against a wide range of gram positive and gram negative aerobic and anaerobic bacterias, histamine h2-receptor antagonist in the treatment of gastric and duodenal ulcer, zollinger-ellison syndrome, for iron deficiency and anemia for children or adults, anixolytic , anticonvulsant, sedative, muscle relaxant, histamine h2-receptor antagonist in the treatment of gastric and duodenal ulcer zollinger-ellison syndrome, multivitamin treatment and prevention of vitamin b1-b6-b12 deficiency, tricyclic antidepressant, treatment of nocturnal enuresis in children, inhibition of angiotensin-converting enzyme, treatment of hypertension and congestive heart failure, treatment and prevention of vitamin C deficiency, treatment and prevention of seborrhea and dandruff, and as an analgesic not narcotic | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Laboratorios Silanes S.A. DE C.V.
- Other trademarks owned by Laboratorios Silanes S.A. DE C.V.
- Other trademarks owned by Laboratorios Silanes S.A. DE C.V.
- Other trademarks in Class 005
- Similar marks named SILANES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 23, 2021 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 16, 2019 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 16, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 9, 2014 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Aug 29, 2014 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 24, 2014 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Aug 24, 2014 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Jul 8, 2014 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 13, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 13, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 23, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 9, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 8, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 8, 2014 | DMCC | DATA MODIFICATION COMPLETED | — |
| Apr 7, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 7, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 30, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 22, 2013 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 22, 2013 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 22, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 31, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 30, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 30, 2013 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 30, 2013 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 17, 2013 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 17, 2013 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 17, 2013 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 7, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 7, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 30, 2013 | ALIE | ASSIGNED TO LIE | — |
| May 28, 2013 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| May 27, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 27, 2013 | PETG | PETITION TO REVIVE-GRANTED | — |
| May 27, 2013 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Apr 17, 2013 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 17, 2013 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 19, 2012 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 19, 2012 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 19, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| May 31, 2012 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| May 30, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 25, 2012 | NWAP | NEW APPLICATION ENTERED | — |